Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

Coronavirus disease 2019 (COVID-19) has already raised serious concern globally as the
number of confirmed or suspected cases have increased rapidly. Epidemiological studies …

Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family
of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart …

Proton pump inhibitors (PPIs) marked a before and after in the management of gastric acid‐
related disorders since their introduction to the market in 1989. Due to a novel, highly …

Proton pump inhibitors (PPIs) have been increasingly used over the last decades and there
are concerns about overuse and the numerous reported side-effects. It is uncertain whether …

Proton pump inhibitors (PPIs) are an antacid drug often used in acid-related disorders. They
decrease acid secretion in the stomach by blocking an enzyme called H+/K+ ATPase which …

Abstract Background and Aims: The impact of statin on dementia risk reduction has been a
subject of debate over the last decade, but the evidence remains inconclusive. Therefore …

Summary Background Proton pump inhibitors (PPIs) are widely used to treat and prevent
acid‐related disorders. Despite high efficacy, PPI safety has been increasingly scrutinised …

Background To examine the association between regular use of proton pump inhibitors and
the risk of incident dementia, including dementia subtypes, and whether the association …